AstraZeneca PLC (NYSE:AZN)

During the Trading Day
65.61 +0.49 / +0.75%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
65.65 +0.04 / +0.06%
Volume: 911.00
Health Technology
Pharmaceuticals: Major

Company Description

AstraZeneca Plc is a global research-based biopharmaceutical company, which primarily focuses on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. The company sells products under the brands Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on April 6, 1999 and is headquartered in London, the United Kingdom.

Contact Information

AstraZeneca Plc
2 Kingdom Street
London London & South East W2 6BD
Investor Relations:



Mutual fund holders4.02%
Other institutional3.69%
Individual stakeholders--

Top Executives

Pascal SoriotChief Executive Officer & Executive Director
Pam P. ChengExecutive VP-Operations & Information Technology
Marc DunoyerChief Financial Officer & Executive Director
Edward BradleySenior VP-Research & Development
Katarina AgeborgChief Compliance Officer

To view my watchlist

Not a member yet?

Sign up now for a free account